Look for:

Our offer for

ELI LILLY AND COMPANY


ISIN:
US5324571083
WKN:
532457108

2023/01/26 22:03:13
Price
348.01 USD
Difference -0.49% (-1.72)

General attributes

ISINUS5324571083
SymbolLLY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)316,127 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)345.01 USD (100)
Ask (Ask size)347.68 USD (100)
Open351.00 USD
High352.18 USD
Low346.73 USD
Close (prev. day)349.73 USD
VWAP348.282154 USD
Volume (pcs)2,576,176
Trading volume897,678,983.16
Number of trades50,938
Last size267,726

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: ELI LILLY AND COMPANYPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2023/01/26 22:03:13
Price
348.01 USD
Difference -0.49% (-1.72)

General attributes

ISINUS5324571083
SymbolLLY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)316,127 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)345.01 USD (100)
Ask (Ask size)347.68 USD (100)
Open351.00 USD
High352.18 USD
Low346.73 USD
Close (prev. day)349.73 USD
VWAP348.282154 USD
Volume (pcs)2,576,176
Trading volume897,678,983.16
Number of trades50,938
Last size267,726

Performance and Risk

6m1Y3Y
Perf (%)-2.50%+51.06%+153.33%
Perf (abs.)-8.20+108.00+193.38
Beta0.420.530.65
Volatility27.0328.9035.29
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)347.10 USD (3,239,826)
Ø price 30 days | Ø volume 30 days (pcs.)358.99 USD (2,617,155)
Ø price 100 days | Ø volume 100 days (pcs.)345.60 USD (2,883,082)
Ø price 250 days | Ø volume 250 days (pcs.)314.30 USD (2,864,498)
YTD High | date384.44 USD (2023/01/24)
YTD Low | date302.14 USD (2023/01/24)
52 Weeks High | date384.44 USD (2023/01/24)
52 Weeks Low | date231.87 USD (2022/02/14)

All listings for ELI LILLY AND COMPANY

Exchange  DateTimePriceTrading volume (mio.)Number of trades
BX Swiss2023/01/2318:00316.987 CHF0.011
Berlin2023/01/2614:05322.40 EUR0.012
Duesseldorf2023/01/2621:01317.70 EUR0.0012
Frankfurt2023/01/2616:48320.75 EUR0.015
Hamburg2023/01/2608:13320.60 EUR0.001
Hanover2023/01/2608:13320.60 EUR0.001
London Stock Exchange2021/12/1015:37225.3104 CHF0.021
Munich2023/01/2608:05320.50 EUR0.001
NYSE2023/01/2622:03348.01 USD897.6850,938
SIX Swiss Exchange2023/01/1717:30332.00 CHF0.011
Stuttgart2023/01/2613:22322.35 EUR0.036
Tradegate2023/01/2622:26319.50 EUR0.4068
Vienna Stock Exchange2023/01/2617:32320.95 EUR0.002
Xetra2023/01/2617:35320.80 EUR0.0719

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=262&ID_TYPE_IMAGE_LOGO=2

Contact Details

ELI LILLY & CO.
- -
Lilly Corporate Center - 46285 Indianapolis
Telefon: 1-317-276-2000
Fax: -
E-mail: communications_corporate@lilly.com

PDF Downloads

Company report: ELI LILLY AND COMPANYPDF Download

Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Members of Management Board

Katherine BaickerMember of Board of Directors
Marschall RungeMember of Board of Directors
Mary Lynne HedleyMember of Board of Directors
William KaelinMember of Board of Directors
Gabrielle Greene-SulzbergerMember of Board of Directors
Jackson TaiMember of Board of Directors
Jamere JacksonMember of Board of Directors
Jon FyrwaldMember of Board of Directors
Juan LucianoMember of Board of Directors
Karen WalkerMember of Board of Directors
Kimberly JohnsonMember of Board of Directors
Ralph AlvarezMember of Board of Directors
David A. RicksChairman of Managing Board
Daniel M. SkovronskyMember of Executive Committee
Alfonso G. ZuluetaMember of Executive Committee
Alonzo WeemsMember of Executive Committee
Anat AshkenaziMember of Executive Committee
Anat HakimMember of Executive Committee
Anne E. WhiteMember of Executive Committee
Diogo RauMember of Executive Committee
Edgardo HernandezMember of Executive Committee
Ilya YuffaMember of Executive Committee
Jacob Van NaardenMember of Executive Committee
Johna NortonMember of Executive Committee
Leigh Ann PuseyMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer